PAGB publish new report for members – Reclassification: a strategic business initiative, not just a regulatory task

PAGB has published a new report for our members which provides an in-depth analysis of the reclassification landscape for OTC medicines in the UK following the Department of Health and Social Care (DHSC) announcement in early 2025.

This week, PAGB published a new report for our members which provides an in-depth analysis of the reclassification landscape for over-the-counter (OTC) medicines in the UK, following the Department of Health and Social Care (DHSC) announcement in early 2025.

Drawing upon insights from PAGB member companies, it highlights both the strategic significance and the operational challenges of reclassification as a business initiative. The findings reveal that reclassification is increasingly viewed as a cross-functional opportunity, requiring close collaboration across regulatory, commercial, and scientific teams.

The report recommends practical solutions and strategic recommendations essential to unlocking further innovation and growth in the consumer healthcare sector, supporting the aims of the NHS 10 Year Health Plan, and ultimately improving patient access to safe and effective self-care options.

The report can be viewed here.

Related news

Self-Care Week blog post from Mark Burdon

Our final blog post this Self-Care Week delves into the pivotal role that pharmacies are playing in the Government’s 10 Year Health Plan. Mark explores the impact of Pharmacy First paving the way, the current challenges that the Government should be prioritising and how digital tools can bring support pharmacists as they widen access to self-care and help streamline patient journeys.

Self-Care Week blog post from Mark Burdon
View all